Significance of a frozen section analysis of the ureteral margin in bladder cancer patients treated with radical cystectomy and neoadjuvant chemotherapy

Kyohei Hakozaki, Eiji Kikuchi, Keishiro Fukumoto, Suguru Shirotake, Yasumasa Miyazaki, Takahiro Maeda, Gou Kaneko, Shunsuke Yoshimine, Nobuyuki Tanaka, Kunimitsu Kanai, Masafumi Oyama, Yosuke Nakajima, Tetsuo Momma, Mototsugu Oya

Research output: Contribution to journalArticle

Abstract

Although the clinical utility of a frozen section analysis (FSA) at the time of radical cystectomy (RC) has already been established, its significance and utility in bladder cancer patients receiving neoadjuvant chemotherapy (NAC) have not yet been fully evaluated. We identified 458 patients (937 ureters) who underwent open RC for bladder cancer at our 7 Japanese institutions between 2004 and 2015. Among these patients, 139 (284 ureters) received NAC before RC (NAC group), while 319 (653 ureters) underwent RC alone (non-NAC group). FSA was performed on 356 out of 937 (38.0%) ureters and 179 out of 458 (39.1%) patients. FSA was positive in 30 out of 356 (8.4%) ureters and its sensitivity, specificity, and accuracy were 89.3, 98.5, and 97.8%, respectively. In the NAC group, FSA was performed on 138 out of 284 (48.6%) ureters and 68 out of 139 (48.9%) patients. FSA was positive in 8 out of 138 ureters (5.8%), and its sensitivity, specificity, and accuracy were 77.8, 99.2, and 97.8%, respectively. In the non-NAC group, FSA was performed on 218 out of 653 (33.4%) ureters and 111 out of 319 (34.8%) patients. FSA was positive in 22 out of 218 (10.1%) ureters, and its sensitivity, specificity, and accuracy were 94.7, 98.0, and 97.7%, respectively. No correlation was observed between preoperative clinical factors and FSA positivity in the NAC group; however, in the non-NAC group, the incidence of FSA positivity in the ureters of patients with concomitant CIS in TUR-BT specimens was 8/41 (19.5%), which was significantly higher than that in their counterpart (14/177, 7.9%, p = 0.033). Even in the era of NAC in the management of bladder cancer patients, the performance of FSA does not change and FSA at the time of RC may provide useful diagnostic information.

Original languageEnglish
Article number187
JournalMedical Oncology
Volume34
Issue number12
DOIs
Publication statusPublished - 2017 Dec 1

Fingerprint

Cystectomy
Frozen Sections
Urinary Bladder Neoplasms
Ureter
Drug Therapy
Sensitivity and Specificity

Keywords

  • Bladder cancer
  • Frozen section analysis
  • Neoadjuvant chemotherapy
  • Radical cystectomy
  • Ureters

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Significance of a frozen section analysis of the ureteral margin in bladder cancer patients treated with radical cystectomy and neoadjuvant chemotherapy. / Hakozaki, Kyohei; Kikuchi, Eiji; Fukumoto, Keishiro; Shirotake, Suguru; Miyazaki, Yasumasa; Maeda, Takahiro; Kaneko, Gou; Yoshimine, Shunsuke; Tanaka, Nobuyuki; Kanai, Kunimitsu; Oyama, Masafumi; Nakajima, Yosuke; Momma, Tetsuo; Oya, Mototsugu.

In: Medical Oncology, Vol. 34, No. 12, 187, 01.12.2017.

Research output: Contribution to journalArticle

Hakozaki, K, Kikuchi, E, Fukumoto, K, Shirotake, S, Miyazaki, Y, Maeda, T, Kaneko, G, Yoshimine, S, Tanaka, N, Kanai, K, Oyama, M, Nakajima, Y, Momma, T & Oya, M 2017, 'Significance of a frozen section analysis of the ureteral margin in bladder cancer patients treated with radical cystectomy and neoadjuvant chemotherapy', Medical Oncology, vol. 34, no. 12, 187. https://doi.org/10.1007/s12032-017-1048-5
Hakozaki, Kyohei ; Kikuchi, Eiji ; Fukumoto, Keishiro ; Shirotake, Suguru ; Miyazaki, Yasumasa ; Maeda, Takahiro ; Kaneko, Gou ; Yoshimine, Shunsuke ; Tanaka, Nobuyuki ; Kanai, Kunimitsu ; Oyama, Masafumi ; Nakajima, Yosuke ; Momma, Tetsuo ; Oya, Mototsugu. / Significance of a frozen section analysis of the ureteral margin in bladder cancer patients treated with radical cystectomy and neoadjuvant chemotherapy. In: Medical Oncology. 2017 ; Vol. 34, No. 12.
@article{2cd01134b2d14da89ffa4a34847f24ad,
title = "Significance of a frozen section analysis of the ureteral margin in bladder cancer patients treated with radical cystectomy and neoadjuvant chemotherapy",
abstract = "Although the clinical utility of a frozen section analysis (FSA) at the time of radical cystectomy (RC) has already been established, its significance and utility in bladder cancer patients receiving neoadjuvant chemotherapy (NAC) have not yet been fully evaluated. We identified 458 patients (937 ureters) who underwent open RC for bladder cancer at our 7 Japanese institutions between 2004 and 2015. Among these patients, 139 (284 ureters) received NAC before RC (NAC group), while 319 (653 ureters) underwent RC alone (non-NAC group). FSA was performed on 356 out of 937 (38.0{\%}) ureters and 179 out of 458 (39.1{\%}) patients. FSA was positive in 30 out of 356 (8.4{\%}) ureters and its sensitivity, specificity, and accuracy were 89.3, 98.5, and 97.8{\%}, respectively. In the NAC group, FSA was performed on 138 out of 284 (48.6{\%}) ureters and 68 out of 139 (48.9{\%}) patients. FSA was positive in 8 out of 138 ureters (5.8{\%}), and its sensitivity, specificity, and accuracy were 77.8, 99.2, and 97.8{\%}, respectively. In the non-NAC group, FSA was performed on 218 out of 653 (33.4{\%}) ureters and 111 out of 319 (34.8{\%}) patients. FSA was positive in 22 out of 218 (10.1{\%}) ureters, and its sensitivity, specificity, and accuracy were 94.7, 98.0, and 97.7{\%}, respectively. No correlation was observed between preoperative clinical factors and FSA positivity in the NAC group; however, in the non-NAC group, the incidence of FSA positivity in the ureters of patients with concomitant CIS in TUR-BT specimens was 8/41 (19.5{\%}), which was significantly higher than that in their counterpart (14/177, 7.9{\%}, p = 0.033). Even in the era of NAC in the management of bladder cancer patients, the performance of FSA does not change and FSA at the time of RC may provide useful diagnostic information.",
keywords = "Bladder cancer, Frozen section analysis, Neoadjuvant chemotherapy, Radical cystectomy, Ureters",
author = "Kyohei Hakozaki and Eiji Kikuchi and Keishiro Fukumoto and Suguru Shirotake and Yasumasa Miyazaki and Takahiro Maeda and Gou Kaneko and Shunsuke Yoshimine and Nobuyuki Tanaka and Kunimitsu Kanai and Masafumi Oyama and Yosuke Nakajima and Tetsuo Momma and Mototsugu Oya",
year = "2017",
month = "12",
day = "1",
doi = "10.1007/s12032-017-1048-5",
language = "English",
volume = "34",
journal = "Medical Oncology",
issn = "1357-0560",
publisher = "Humana Press",
number = "12",

}

TY - JOUR

T1 - Significance of a frozen section analysis of the ureteral margin in bladder cancer patients treated with radical cystectomy and neoadjuvant chemotherapy

AU - Hakozaki, Kyohei

AU - Kikuchi, Eiji

AU - Fukumoto, Keishiro

AU - Shirotake, Suguru

AU - Miyazaki, Yasumasa

AU - Maeda, Takahiro

AU - Kaneko, Gou

AU - Yoshimine, Shunsuke

AU - Tanaka, Nobuyuki

AU - Kanai, Kunimitsu

AU - Oyama, Masafumi

AU - Nakajima, Yosuke

AU - Momma, Tetsuo

AU - Oya, Mototsugu

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Although the clinical utility of a frozen section analysis (FSA) at the time of radical cystectomy (RC) has already been established, its significance and utility in bladder cancer patients receiving neoadjuvant chemotherapy (NAC) have not yet been fully evaluated. We identified 458 patients (937 ureters) who underwent open RC for bladder cancer at our 7 Japanese institutions between 2004 and 2015. Among these patients, 139 (284 ureters) received NAC before RC (NAC group), while 319 (653 ureters) underwent RC alone (non-NAC group). FSA was performed on 356 out of 937 (38.0%) ureters and 179 out of 458 (39.1%) patients. FSA was positive in 30 out of 356 (8.4%) ureters and its sensitivity, specificity, and accuracy were 89.3, 98.5, and 97.8%, respectively. In the NAC group, FSA was performed on 138 out of 284 (48.6%) ureters and 68 out of 139 (48.9%) patients. FSA was positive in 8 out of 138 ureters (5.8%), and its sensitivity, specificity, and accuracy were 77.8, 99.2, and 97.8%, respectively. In the non-NAC group, FSA was performed on 218 out of 653 (33.4%) ureters and 111 out of 319 (34.8%) patients. FSA was positive in 22 out of 218 (10.1%) ureters, and its sensitivity, specificity, and accuracy were 94.7, 98.0, and 97.7%, respectively. No correlation was observed between preoperative clinical factors and FSA positivity in the NAC group; however, in the non-NAC group, the incidence of FSA positivity in the ureters of patients with concomitant CIS in TUR-BT specimens was 8/41 (19.5%), which was significantly higher than that in their counterpart (14/177, 7.9%, p = 0.033). Even in the era of NAC in the management of bladder cancer patients, the performance of FSA does not change and FSA at the time of RC may provide useful diagnostic information.

AB - Although the clinical utility of a frozen section analysis (FSA) at the time of radical cystectomy (RC) has already been established, its significance and utility in bladder cancer patients receiving neoadjuvant chemotherapy (NAC) have not yet been fully evaluated. We identified 458 patients (937 ureters) who underwent open RC for bladder cancer at our 7 Japanese institutions between 2004 and 2015. Among these patients, 139 (284 ureters) received NAC before RC (NAC group), while 319 (653 ureters) underwent RC alone (non-NAC group). FSA was performed on 356 out of 937 (38.0%) ureters and 179 out of 458 (39.1%) patients. FSA was positive in 30 out of 356 (8.4%) ureters and its sensitivity, specificity, and accuracy were 89.3, 98.5, and 97.8%, respectively. In the NAC group, FSA was performed on 138 out of 284 (48.6%) ureters and 68 out of 139 (48.9%) patients. FSA was positive in 8 out of 138 ureters (5.8%), and its sensitivity, specificity, and accuracy were 77.8, 99.2, and 97.8%, respectively. In the non-NAC group, FSA was performed on 218 out of 653 (33.4%) ureters and 111 out of 319 (34.8%) patients. FSA was positive in 22 out of 218 (10.1%) ureters, and its sensitivity, specificity, and accuracy were 94.7, 98.0, and 97.7%, respectively. No correlation was observed between preoperative clinical factors and FSA positivity in the NAC group; however, in the non-NAC group, the incidence of FSA positivity in the ureters of patients with concomitant CIS in TUR-BT specimens was 8/41 (19.5%), which was significantly higher than that in their counterpart (14/177, 7.9%, p = 0.033). Even in the era of NAC in the management of bladder cancer patients, the performance of FSA does not change and FSA at the time of RC may provide useful diagnostic information.

KW - Bladder cancer

KW - Frozen section analysis

KW - Neoadjuvant chemotherapy

KW - Radical cystectomy

KW - Ureters

UR - http://www.scopus.com/inward/record.url?scp=85042350212&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042350212&partnerID=8YFLogxK

U2 - 10.1007/s12032-017-1048-5

DO - 10.1007/s12032-017-1048-5

M3 - Article

VL - 34

JO - Medical Oncology

JF - Medical Oncology

SN - 1357-0560

IS - 12

M1 - 187

ER -